title: Differentiation of eosinophils from cord blood cell precursors: kinetics of Fc epsilon RI and Fc epsilon RII expression.
abstract: Expression of Fc epsilonRI and Fc epsilonRII/CD23 was examined by immunocytochemistry and flow cytometry on eosinophils differentiated from human cord blood cells in the presence of human interleukin-3 (rhIL-3), granulocyte/macrophage colony stimulating factor (rhGM-CSF) and interleukin-5 (rhIL-5) and on blood eosinophils purified from normal donors or patients with idiopathic hypereosinophilic syndrome (HES). On cord blood derived eosinophils, Fc epsilonRI expression started at 1 week of culture and increased to reach a plateau at 3 weeks of culture. Fc epsilonRII/CD23 appeared slightly later, after 2 weeks of culture, and the percentage of Fc epsilonRII/CD23-positive eosinophilic cells increased and stayed in plateau. Fc epsilonRI expression on cord blood derived eosinophils was downregulated after culture with interleukin-2 (rhIL-2), interleukin-4 (rhIL-4), rhIL-5, interferon-alpha (rhIFN-alpha), interferon-gamma (rhIFN-gamma). In contrast, the expression of Fc epsilonRII/CD23 on cord blood derived eosinophilic cells was upregulated after culture with rhIL-4, rhIL-5 and rhIFN-gamma, and downregulated with rhIL-2 and rhIFN-alpha. Fc epsilonRI was expressed on about 30% normal donor eosinophils as well as on normodense eosinophils from HES patients but significantly decreased on hypodense eosinophils. In contrast, Fc epsilonRII/CD23, expressed on a very small proportion of normal donor eosinophils, increased from normodense to hypodense eosinophils. These results suggest that Fc epsilonRI on eosinophils might represent one differentiation antigen expressed relatively early, with decreased expression through maturation or activation, whereas Fc epsilonRII/CD23 might rather be considered as a marker of eosinophil activation.
authors.affiliation: Centre d'Immunologie et de Biologie Parasitaire, Unité INSERM U167, Institut Pasteur, Lille, France.
authors.forename: M
authors.initials: M
authors.lastname: Capron
authors.forename: M
authors.initials: M
authors.lastname: Morita
authors.forename: G
authors.initials: G
authors.lastname: Woerly
authors.forename: F
authors.initials: F
authors.lastname: Lengrand
authors.forename: A S
authors.initials: AS
authors.lastname: Gounni
authors.forename: E
authors.initials: E
authors.lastname: Delaporte
authors.forename: A
authors.initials: A
authors.lastname: Capron
mesh_terms: D002454:Cell Differentiation; D016207:Cytokines / Q000494:pharmacology; D004804:Eosinophils / Q000737:chemistry*; D005312:Fetal Blood / Q000166:cytology*; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D007700:Kinetics; D017455:Receptors, IgE / Q000032:analysis*
chemical_list: D016207:Cytokines; D017455:Receptors, IgE